These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31602725)

  • 1. Atrial fibrillation is frequent but does not affect risk stratification in pulmonary embolism.
    Ebner M; Rogge NIJ; Parwani AS; Sentler C; Lerchbaumer MH; Pieske B; Konstantinides SV; Hasenfuß G; Wachter R; Lankeit M
    J Intern Med; 2020 Jan; 287(1):100-113. PubMed ID: 31602725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation).
    Hijazi Z; Wallentin L; Siegbahn A; Andersson U; Christersson C; Ezekowitz J; Gersh BJ; Hanna M; Hohnloser S; Horowitz J; Huber K; Hylek EM; Lopes RD; McMurray JJ; Granger CB
    J Am Coll Cardiol; 2013 Jun; 61(22):2274-84. PubMed ID: 23563134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syncope in the German Nationwide inpatient sample - Syncope in atrial fibrillation/flutter is related to pulmonary embolism and is accompanied by higher in-hospital mortality.
    Keller K; Hobohm L; Münzel T; Ostad MA
    Eur J Intern Med; 2019 Apr; 62():29-36. PubMed ID: 30770163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.
    Roldán V; Vílchez JA; Manzano-Fernández S; Jover E; Gálvez J; Puche CM; Valdés M; Vicente V; Lip GY; Marín F
    Stroke; 2014 Mar; 45(3):696-701. PubMed ID: 24519407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.
    Proietti M; Laroche C; Drozd M; Vijgen J; Cozma DC; Drozdz J; Maggioni AP; Boriani G; Lip GY;
    Am Heart J; 2016 Nov; 181():83-91. PubMed ID: 27823697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.
    Eckstein J; Potocki M; Murray K; Breidthardt T; Ziller R; Mosimann T; Klima T; Hoeller R; Moehring B; Sou SM; Rubini Gimenez M; Morgenthaler NG; Mueller C
    Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal pro-brain natriuretic peptide or troponin testing followed by echocardiography for risk stratification of acute pulmonary embolism.
    Binder L; Pieske B; Olschewski M; Geibel A; Klostermann B; Reiner C; Konstantinides S
    Circulation; 2005 Sep; 112(11):1573-9. PubMed ID: 16144990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated admission N-terminal pro-brain natriuretic peptide level predicts the development of atrial fibrillation in general surgical intensive care unit patients.
    Chokengarmwong N; Yeh DD; Chang Y; Ortiz LA; Kaafarani HMA; Fagenholz P; King DR; DeMoya M; Butler K; Lee J; Velmahos G; Januzzi JL; Lee-Lewandrowski E; Lewandrowski K
    J Trauma Acute Care Surg; 2017 Sep; 83(3):485-490. PubMed ID: 28463935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NT-proBNP is a powerful predictor for incident atrial fibrillation - Validation of a multimarker approach.
    Svennberg E; Lindahl B; Berglund L; Eggers KM; Venge P; Zethelius B; Rosenqvist M; Lind L; Hijazi Z
    Int J Cardiol; 2016 Nov; 223():74-81. PubMed ID: 27541645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [NT-proBNP for risk stratification of pulmonary embolism].
    Dores H; Fonseca C; Leal S; Rosário I; Abecasis J; Monge J; Correia MJ; Bronze L; Leitão A; Arroja I; Aleixo A; Silva A
    Rev Port Cardiol; 2011 Dec; 30(12):881-6. PubMed ID: 22100750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between left atrial appendage emptying velocity, N-terminal plasma brain natriuretic peptide levels, and recurrence of atrial fibrillation after catheter ablation.
    Ma XX; Zhang YL; Hu B; Jiang WJ; Wang M; Zheng DY; Zhu MR; Xue XP
    J Interv Card Electrophysiol; 2017 Apr; 48(3):343-350. PubMed ID: 27943042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial fibrillation and amino-terminal pro-brain natriuretic peptide as independent predictors of prognosis in systolic heart failure.
    Dini FL; Gabutti A; Passino C; Fontanive P; Emdin M; De Tommasi SM
    Int J Cardiol; 2010 Apr; 140(3):344-50. PubMed ID: 19128846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Midregional proadrenomedullin (MR-proADM) in the risk stratification of patients with acute pulmonary embolism.
    Pedowska-Włoszek J; Kostrubiec M; Kurnicka K; Ciurzynski M; Palczewski P; Pruszczyk P
    Thromb Res; 2013 Nov; 132(5):506-10. PubMed ID: 24060192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial Fibrillation and Cause-Specific Risks of Pulmonary Embolism and Ischemic Stroke.
    Hald EM; Rinde LB; Løchen ML; Mathiesen EB; Wilsgaard T; Njølstad I; Brækkan SK; Hansen JB
    J Am Heart Assoc; 2018 Jan; 7(3):. PubMed ID: 29378729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrillation in acute pulmonary embolism: prognostic considerations.
    Barra SN; Paiva LV; Providência R; Fernandes A; Leitão Marques A
    Emerg Med J; 2014 Apr; 31(4):308-12. PubMed ID: 23349355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal pro-brain natriuretic peptide levels had an independent and added ability in the evaluation of all-cause mortality in older Chinese patients with atrial fibrillation.
    Fu S; Jiao J; Guo Y; Zhu B; Luo L
    BMC Geriatr; 2019 Feb; 19(1):56. PubMed ID: 30819103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective cohort study of new-onset atrial fibrillation in acute pulmonary embolism on prognosis.
    Liu D; Shi S; Liu X; Ye T; Wang L; Qu C; Yang B; Zhao Q
    BMJ Open; 2021 Sep; 11(9):e047658. PubMed ID: 34551942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume.
    Lam CS; Rienstra M; Tay WT; Liu LC; Hummel YM; van der Meer P; de Boer RA; Van Gelder IC; van Veldhuisen DJ; Voors AA; Hoendermis ES
    JACC Heart Fail; 2017 Feb; 5(2):92-98. PubMed ID: 28017355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Prevalence and Incidence of Atrial Fibrillation in Patients with Acute Pulmonary Embolism.
    Ng AC; Adikari D; Yuan D; Lau JK; Yong AS; Chow V; Kritharides L
    PLoS One; 2016; 11(3):e0150448. PubMed ID: 26930405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of NT-proANP and NT-proBNP in patients with atrial fibrillation: Association with atrial fibrillation progression phenotypes.
    Büttner P; Schumacher K; Dinov B; Zeynalova S; Sommer P; Bollmann A; Husser D; Hindricks G; Kornej J
    Heart Rhythm; 2018 Aug; 15(8):1132-1137. PubMed ID: 29604419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.